Latest Cancer immunotherapy Stories
SOUTH SAN FRANCISCO, Calif., May 28, 2015 /PRNewswire/ -- CytomX, a biotechnology company developing Probody(TM) therapeutics for the treatment of cancer, today announced that Sean McCarthy,
NORTH BRUNSWICK, N.J., May 28, 2015 /PRNewswire/ -- PDS Biotechnology Corp.
Cancer Immunotherapy Month Focuses on Raising Awareness for the Most Promising Form of Cancer Treatment Today New York (PRWEB) May 20, 2015 Cancer immunotherapy,
SAN DIEGO, May 20, 2015 /PRNewswire/ -- OncoSec Medical Inc.
MAINZ, Germany, May 19, 2015 /PRNewswire/ -- Collaboration with Genmab will focus on novel bispecific antibody products in immuno-oncology BioNTech AG, a
SAN DIEGO, May 18, 2015 /PRNewswire/ -- OncoSec Medical Inc.
ROCKLAND, Massachusetts, May 15, 2015 /PRNewswire/ -- ASCO Abstract # Avelumab*: 3023, 3044, 3055, TPS9386, TPS3101, 4042, 4047, 5509, 8034; evofosfamide: TPS9089, 8579;
LONDON, May 13, 2015 /PRNewswire/ -- INTRODUCTIONCancer is known to be one of the leading causes of death worldwide.
Phase 3 Registration Trial for ICT-107 to Initiate in Second Half of 2015; Financial Results Conference Call to be Held on May 12, 2015 LOS ANGELES, May 11, 2015 /PRNewswire/ -- ImmunoCellular
INDIANAPOLIS and MAINZ, Germany, May 11, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and BioNTech AG today announced they have entered into a research collaboration to discover novel
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.